Skip to content

Relationship Between Kidney-invigorating Treatment Improving Mitochondrial Function of Repeated COS Oocyte and Regulating Nrf2 Antioxidant Stress Pathway

Relationship Between Kidney-invigorating Treatment Improving Mitochondrial Function of Repeated COS Oocyte and Regulating Nrf2 Antioxidant Stress Pathway

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013157
Enrollment
Unknown
Registered
2017-10-30
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

first COS group:nothing
repeated COS group:palcebo
repeated COS and Chinese medcine group:Chinese medicine

Sponsors

Hebei University of Chinese Medcine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Infertility women; (2) Meet the diagnostic criteria of kidney deficiency syndrome; (3) Aged 35 years old or less; (4) Regular menstruation (25-35 days); (5) Basic FSH< 10miu/ml, basic FSH/LH< 3.6; (6) The COS frequency was 3-5 times and the control group was the first COS; (7) Signed the informed consent.;Inclusion criteria: (1) Infertility women; (2) Meet the diagnostic criteria of kidney deficiency syndrome; (3) Aged 35 years old or less; (4) Regular menstruation (25-35 days); (5) Basic FSH< 10miu/ml, basic FSH/LH< 3.6; (6) The COS frequency was 3-5 times and the control group was the first COS; (7) Signed the informed consent.;Inclusion criteria: (1) Infertility women; (2) Meet the diagnostic criteria of kidney deficiency syndrome; (3) Aged 35 years old or less; (4) Regular menstruation (25-35 days); (5) Basic FSH< 10miu/ml, basic FSH/LH< 3.6; (6) The COS frequency was 3-5 times and the control group was the first COS; (7) Signed the informed consent.;Inclusion criteria: (1) Infertility women; (2) Meet the diagnostic criteria of kidney deficiency syndrome; (3) Aged 35 years old or less; (4) Regular menstruation (25-35 days); (5) Basic FSH< 10miu/ml, basic FSH/LH< 3.6; (6) The COS frequency was 3-5 times and the control group was the first COS; (7) Signed the informed consent.;Inclusion criteria: (1) Infertility women; (2) Meet the diagnostic criteria of kidney deficiency syndrome; (3) Aged 35 years old or less; (4) Regular menstruation (25-35 days); (5) Basic FSH< 10miu/ml, basic FSH/LH< 3.6; (6) The COS frequency was 3-5 times and the control group was the first COS; (7) Signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Uterus does not have function of pregnancy or serious body disease cannot bear, suffering from severe mental disorders, pregnancy infections, sexually transmitted disease, genitourinary system, has the serious bad habits such as drug abuse, the amount of contact with birth defects rays, or poison and is in effect; (2) Endometriosis, uterine fibroids, tuberculosis, intrauterine adhesions, endometrial lesions; (3) Polycystic ovary syndrome, ovarian cyst, fallopian tube water; (4) Not conforming to the inclusion criteria, can't take medicine as prescribed, etc.;Exclusion criteria: (1) Uterus does not have function of pregnancy or serious body disease cannot bear, suffering from severe mental disorders, pregnancy infections, sexually transmitted disease, genitourinary system, has the serious bad habits such as drug abuse, the amount of contact with birth defects rays, or poison and is in effect; (2) Endometriosis, uterine fibroids, tuberculosis, intrauterine adhesions, endometrial lesions; (3) Polycystic ovary syndrome, ovarian cyst, fallopian tube water; (4) Not conforming to the inclusion criteria, can't take medicine as prescribed, etc.;Exclusion criteria: (1) Uterus does not have function of pregnancy or serious body disease cannot bear, suffering from severe mental disorders, pregnancy infections, sexually transmitted disease, genitourinary system, has the serious bad habits such as drug abuse, the amount of contact with birth defects rays, or poison and is in effect; (2) Endometriosis, uterine fibroids, tuberculosis, intrauterine adhesions, endometrial lesions; (3) Polycystic ovary syndrome, ovarian cyst, fallopian tube water; (4) Not conforming to the inclusion criteria, can't take medicine as prescribed, etc.;Exclusion criteria: (1) Uterus does not have function of pregnancy or serious body disease cannot bear, suffering from severe mental disorders, pregnancy infections, sexually transmitted disease, genitourinary system, has the serious bad habits such as drug abuse, the amount of contact with birth defects rays, or poison and is in effect; (2) Endometriosis, uterine fibroids, tuberculosis, intrauterine adhesions, endometrial lesions; (3) Polycystic ovary syndrome, ovarian cyst, fallopian tube water; (4) Not conforming to the inclusion criteria, can't take medicine as prescribed, etc.;Exclusion criteria: (1) Uterus does not have function of pregnancy or serious body disease cannot bear, suffering from severe mental disorders, pregnancy infections, sexually transmitted disease, genitourinary system, has the serious bad habits such as drug abuse, the amount of contact with birth defects rays, or poison and is in effect; (2) Endometriosis, uterine fibroids, tuberculosis, intrauterine adhesions, endometrial lesions; (3) Polycystic ovary syndrome, ovarian cyst, fallopian tube water; (4) Not conforming to the inclusion criteria, can't take medicine as prescribed, etc.

Design outcomes

Primary

MeasureTime frame
advanced oxidation protein products(AOPP);3-nytrotyrosine(3-NT);4-hydroxynonenal(4-HNE);8-hydroxy-2’-deoxyguanosine(8-OHdG);MDA;total antioxidant capacity (T-AOC);superoxide dismutase(SOD);catalase(CAT);glutathione peroxidase(GSH-Px);NQO1;Mitochondrial ultrastructure of granulosa cells;Mitochondrial distribution of granulosa cells;The ATP content of granulosa cells;membrane potential of granulosa cells;MtDNA copy number of granulosa cells;

Countries

China

Contacts

Public ContactHuilan Du;Huilan Du;Huilan Du;Huilan Du;Huilan Du ;;;;

Hebei University of Chinese Medcine;Hebei University of Chinese Medcine;Hebei University of Chinese Medcine;Hebei University of Chinese Medcine;Hebei University of Chinese Medcine

duhuilan@163.com;duhuilan@163.com;duhuilan@163.com;duhuilan@163.com;duhuilan@163.com+86 13931150880;+86 13931150880;+86 13931150880;+86 13931150880;+86 13931150880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026